CNXC EVP reports insider sale: 500 shares at $42.53; 35,630 held

Rhea-AI Filing Summary

Concentrix Corp (CNXC) reported an insider transaction by its EVP, Global Ops & Delivery. On October 30, 2025, the officer sold 500 shares of common stock at $42.53 per share. The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on January 28, 2025.

Following this transaction, the reporting person beneficially owns 35,630 shares, held directly. This is a routine Form 4 disclosure of an executive’s equity transaction under a pre-established plan.

Insider Trade Summary

Net Seller: 500 shares ($21,265)

Net Sell 1 txn

Insider Twomey Cormac J

Role EVP, Global Ops & Delivery

Sold 500 shs ($21K)

Type	Security	Shares	Price	Value
Sale	Common Stock	500	$42.53	$21K

Holdings After Transaction: Common Stock — 35,630 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Twomey Cormac J

(Last) (First) (Middle)

39899 BALENTINE DRIVE

SUITE 235

(Street)

NEWARK CA 94560

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global Ops & Delivery

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/30/2025		S(1)		500	D	$42.53	35,630	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale was effected pursuant to a Rule 10b5-1 trading plan by the reporting person on January 28, 2025.

Remarks:

	/s/ Andrew A. Farwig, Attorney-in-Fact	10/31/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Concentrix (CNXC) disclose in this Form 4?

An EVP sold 500 shares of common stock at $42.53 on October 30, 2025 under a Rule 10b5-1 plan.

How many CNXC shares does the insider hold after the sale?

The reporting person beneficially owns 35,630 shares directly after the transaction.

Was the CNXC insider sale under a 10b5-1 plan?

Yes. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on January 28, 2025.

What was the transaction price for the CNXC shares?

The reported sale price was $42.53 per share.

What is the insider’s role at Concentrix (CNXC)?

The reporting person is an Officer, serving as EVP, Global Ops & Delivery.

What is the transaction date in the CNXC Form 4?

The transaction occurred on October 30, 2025.